entinostat has been researched along with Sarcoma, Epithelioid in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the mechanism of entinostat, a benzamide-derivative narrow-spectrum HDACi, in augmenting the cytotoxicity of NK cells against human colon carcinoma and sarcoma by assessing gene and protein expression, histone acetylation, and cytotoxicity in in vitro and murine models." | 3.81 | The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells. ( Cobanoglu, ZS; Denman, CJ; Gottschalk, SM; Hughes, DP; Kiany, S; Kleinerman, ES; Lau, CC; Lee, DA; Zhu, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, S | 1 |
| Denman, CJ | 1 |
| Cobanoglu, ZS | 1 |
| Kiany, S | 1 |
| Lau, CC | 1 |
| Gottschalk, SM | 1 |
| Hughes, DP | 1 |
| Kleinerman, ES | 1 |
| Lee, DA | 1 |
1 other study available for entinostat and Sarcoma, Epithelioid
| Article | Year |
|---|---|
The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
Topics: Acetylation; Animals; Antineoplastic Agents; Benzamides; Binding Sites; Cell Line, Tumor; Coculture | 2015 |